Stocks Health care PHGE
NYSE · Health careBiomX Inc. (PHGE)
It posted a net loss of $45.5M. In fiscal 2025 capital spending exceeded operating cash flow by $26.4M. At June 30, 2026 it held $347K in cash against $247K of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 19, 2026.
Key facts about BiomX Inc.
- Net worth
- BiomX Inc. has a market value (market cap) of $49.1M at the latest share price, and shareholders' equity of $10.9M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Cash flow
- In fiscal 2025 operations used $26.4M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 19, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
What BiomX Inc. does
BiomX Inc. is registered with the SEC under industry code SIC 7372 (Services-Prepackaged Software). Its shares trade on NYSE under the ticker PHGE.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$36.2M | $22.19 | -$26.4M |
| 2024 | n/a | -$17.7M | $58.31 | -$37M |
| 2023 | n/a | -$26.2M | $88.51 | -$21.3M |
| 2022 | n/a | -$28.3M | $164.86 | -$29.2M |
| 2021 | n/a | -$36.2M | $241.22 | -$31.3M |
| 2020 | n/a | -$30.1M | $225.60 | -$25.5M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What BiomX Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 6, 2026Activist stake changed SCHEDULE 13D/A
- October 5, 2026Passive stake (5% or more) SCHEDULE 13G
- October 5, 2026Material agreement8-KTessera Defense and Homeland Security secured a new revolving credit line of up to $5,000,000 and issued 2,690,500 common shares.
- September 29, 2026
- September 25, 2026Preliminary proxy statement PRE 14A
- September 25, 2026Material agreement8-KTessera Defense entered into an option agreement to acquire a 51% controlling stake in RT LTA Systems.
- September 22, 2026Material agreement8-KTessera Defense amended its agreement to increase its stake in MEA Testing Systems to 15%, closed the initial 10% acquisition, and secured a technology license.
- September 17, 2026Activist stake (5% or more) SCHEDULE 13D
- September 15, 2026
- September 9, 2026
Insider trades
What the people running BiomX Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| March 17, 2026 | Yeganeh ReuvenDirector, 10% owner | Exercised optionsindirect | 530,000 | $1.1M |
| March 17, 2026 | Yeganeh ReuvenDirector, 10% owner | Soldindirect | 530,000 | $2.7M |
| March 16, 2026 | Yeganeh ReuvenDirector, 10% owner | Exercised optionsindirect | 450,000 | $900K |
| March 16, 2026 | Yeganeh ReuvenDirector, 10% owner | Soldindirect | 450,000 | $2.3M |
| March 13, 2026 | Yeganeh ReuvenDirector, 10% owner | Exercised optionsindirect | 370,000 | $740K |
| March 13, 2026 | Yeganeh ReuvenDirector, 10% owner | Soldindirect | 370,000 | $1.9M |
| March 12, 2026 | Yeganeh ReuvenDirector, 10% owner | Soldindirect | 300,000 | $1.5M |
| March 11, 2026 | Yeganeh ReuvenDirector, 10% owner | Exercised optionsindirect | 300,000 | $600K |
Who owns PHGE
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Pyu Pyu Capital, LLC13D, may seek influence with 1 related filers | 19.99% | January 26, 2026 |
| Mandragola Ltd.13G, passive with 1 related filers | 9.99% | October 5, 2026 |
| Nantahala Capital Management, LLC13G, passive with 2 related filers | 7.13% | August 14, 2026 |
| Ram Naim13D, may seek influence with 1 related filers | 5.3% | October 6, 2026 |
Largest institutional holders
Insiders
Questions about PHGE
What does BiomX Inc. do?
BiomX Inc. is a company in the Health care sector, listed on NYSE as PHGE. Its shares trade on NYSE under the ticker PHGE.
What is BiomX Inc.'s net worth?
BiomX Inc. has a market value (market cap) of $49.1M at the latest share price, and shareholders' equity of $10.9M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is BiomX Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $45.5M.
When did BiomX Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 19, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the activist stake changed from October 6, 2026.
Similar companies
Compare PHGE with
Follow PHGE
Get an email when BiomX Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values BiomX Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.